Vivodyne用机器人实验室生成人体数据，解决AI药物发现瓶颈
原标题：AI isn’t close to curing cancer. This startup says it knows what it will take.
AI 摘要
生物技术初创公司Vivodyne开发了模块化机器人实验室HIVE，可培养20种人体组织并自主进行药物测试，以生成AI模型缺乏的因果生物学数据。该公司认为现有AI药物发现模型因缺乏人体组织数据而效果有限，并已开设全球最大的“人类数据中心”，旨在通过更准确的预测加速药物研发。Vivodyne已融资近8000万美元，并与多家大型制药公司合作。
正文节选
A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a machine to fix it. HIVE, modular robotic labs built by the company, can grow 20 kinds of human tissue, then autonomously dose and monitor them, generating the kind of causal biological data that today’s AI models are missing — data that today mostly comes from animal testing, or studies of single cells or proteins, not living tissue. “Absent human testing, what are these [AI] models